Solas BioVentures
Overview
Solas BioVentures is a venture capital firm that invests exclusively in the life sciences industry, focusing on early-stage biopharmaceuticals, medical devices, digital health technologies, and related opportunities in medicine. The firm maintains a founder-centric approach to enable breakthrough medicine and technology innovation, aiming to positively transform the standard of care and patient outcomes.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Aurenar | Jul 2026 | Seed | Lead |
| PreTeL, Inc. | Jun 2026 | Seed | Co-investor |
| Ceresti Health | Aug 2025 | Series A | Lead |
| Francis Medical | Jan 2025 | Series C | Lead |
| iO Urology | Mar 2024 | Series A | Lead |
Key People
C David Adair
Managing Partner Co-Founder
Mark Hackett
Managing Partner And Co-Founder
Michael Hoey
General Partner
Terry Adams
General Partner
Michael Ackermann
Managing Director
MBA FFPM GFMD Laurent Pacheco
Investor Venture Partner
Lana B. Caron
Partner
A. Travis Manasco
Principal
Joshua Eckelberry
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
